UK recommends PIP breast implants should not be removedBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d8313 (Published 22 December 2011) Cite this as: BMJ 2011;343:d8313
- Adrian O’Dowd
The UK’s drug regulatory body has recommended that women who have been implanted with Poly Implant Prosthese (PIP) breast implants should not have them removed, despite concerns raised in France.
The French regulatory authority AFSSAPS (Agence Française de Sécurité Sanitaire des Produits de Santé) is expected to issue a statement on 23 December on the safety of the implants, after reports of the death of a woman who had this type of implant from anaplastic large cell lymphoma.
However, in the UK, the Medicines and Healthcare products Regulatory Agency has played down fears saying that it has been monitoring the safety of the implants and has concluded there is currently …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial